Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral CBD effects on smoked marijuana
NCT01844687Phase 2Completed
- Sponsor
- National Institute on Drug Abuse
- Start
- May 2013
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of cannabidiol in cannabis use disorder (CUD) (8 arms), sponsored by National Institute on Drug Abuse. Primary endpoint: Mood Scale - Subscale 'Feeling High'. Started May 2013; status: completed.
02
Drugs
cannabidiol
03
Conditions
cannabis use disorder (CUD)
Beyond the preview
Go deeper on NCT01844687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01844687.